GYRE THERAPEUTICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Gyre Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Gyre Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -302 %, a 46.3% increase year-over-year.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2023 was 514 %, a 5199% increase from 2022.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2022 was 9.69 %.
  • Gyre Therapeutics, Inc. annual Return On Equity for 2021 was -121 %, a 102% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -302 +261 +46.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.99K -2.07K -2799% Jan 1, 2024 Mar 31, 2024
Q4 2023 514 +504 +5199% Oct 1, 2023 Dec 31, 2023
Q3 2023 1.04K +1.02K +3781% Jul 1, 2023 Sep 30, 2023
Q2 2023 -563 -546 -3353% Apr 1, 2023 Jun 30, 2023
Q1 2023 73.8 +223 Jan 1, 2023 Mar 31, 2023
Q4 2022 9.69 +131 Oct 1, 2022 Dec 31, 2022
Q3 2022 26.9 +133 Jul 1, 2022 Sep 30, 2022
Q2 2022 -16.3 +69.8 +81.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -150 -71.6 -92% Jan 1, 2022 Mar 31, 2022
Q4 2021 -121 -61.1 -102% Oct 1, 2021 Dec 31, 2021
Q3 2021 -106 -50.9 -92.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -86 -32.6 -60.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -77.9 -26 -50.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -59.7 +3.59 +5.67% Oct 1, 2020 Dec 31, 2020
Q3 2020 -55.2 -2.86 -5.46% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.5 -11.3 -26.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -51.9 -19.4 -59.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -63.3 -40.6 -179% Oct 1, 2019 Dec 31, 2019
Q3 2019 -52.4 -29.7 -131% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.2 -14.7 -53.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -32.6 +6.71 +17.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -22.7 +63.7 +73.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -22.7 +69.2 +75.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -27.5 +65.3 +70.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -39.3 +56.6 +59% Jan 1, 2018 Mar 31, 2018
Q4 2017 -86.4 -8.61 -11.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -91.9 -20.4 -28.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -92.8 -30.4 -48.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -95.9 -436 -128% Jan 1, 2017 Mar 31, 2017
Q4 2016 -77.8 +25.8 +24.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -71.5 -124 -237% Jul 1, 2016 Sep 30, 2016
Q2 2016 -62.5 -482 -115% Apr 1, 2016 Jun 30, 2016
Q1 2016 340 +354 Jan 1, 2016 Mar 31, 2016
Q4 2015 -104 -92.7 -858% Oct 1, 2015 Dec 31, 2015
Q3 2015 52.2 +82 Jul 1, 2015 Sep 30, 2015
Q2 2015 419 +461 Apr 1, 2015 Jun 30, 2015
Q1 2015 -13.8 +35.7 +72.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -10.8 +39.5 +78.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -29.8 +21.9 +42.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -42.2 -0.64 -1.54% Apr 1, 2014 Jun 30, 2014
Q1 2014 -49.5 -34.6 -231% Jan 1, 2014 Mar 31, 2014
Q4 2013 -50.3 -44.4 -749% Oct 1, 2013 Dec 31, 2013
Q3 2013 -51.7 -51.2 -10141% Jul 1, 2013 Sep 30, 2013
Q2 2013 -41.6 -40.5 -3509% Apr 1, 2013 Jun 30, 2013
Q1 2013 -15 -4.55 -43.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -5.93 Oct 1, 2012 Dec 31, 2012
Q3 2012 -0.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -1.15 Apr 1, 2012 Jun 30, 2012
Q1 2012 -10.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.